Comerica Bank grew its stake in shares of Ryan Specialty Holdings, Inc. (NYSE:RYAN - Free Report) by 562.4% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 209,079 shares of the company's stock after buying an additional 177,517 shares during the quarter. Comerica Bank owned about 0.08% of Ryan Specialty worth $13,415,000 as of its most recent filing with the Securities and Exchange Commission.
Other hedge funds have also recently bought and sold shares of the company. Kapitalo Investimentos Ltda purchased a new position in Ryan Specialty during the 4th quarter worth approximately $36,000. Schonfeld Strategic Advisors LLC grew its position in shares of Ryan Specialty by 468.3% in the fourth quarter. Schonfeld Strategic Advisors LLC now owns 122,767 shares of the company's stock valued at $7,877,000 after purchasing an additional 101,164 shares during the last quarter. Northern Trust Corp lifted its position in shares of Ryan Specialty by 20.5% during the 4th quarter. Northern Trust Corp now owns 891,112 shares of the company's stock worth $57,174,000 after purchasing an additional 151,391 shares during the last quarter. The Manufacturers Life Insurance Company lifted its holdings in shares of Ryan Specialty by 2.5% during the fourth quarter. The Manufacturers Life Insurance Company now owns 85,528 shares of the company's stock worth $5,487,000 after buying an additional 2,119 shares during the last quarter. Finally, Aquatic Capital Management LLC lifted its stake in shares of Ryan Specialty by 7,434.4% in the fourth quarter. Aquatic Capital Management LLC now owns 45,357 shares of the company's stock valued at $2,910,000 after buying an additional 44,755 shares during the period. 84.82% of the stock is owned by institutional investors and hedge funds.
Analyst Ratings Changes
A number of analysts have recently weighed in on RYAN shares. Wells Fargo & Company lowered their target price on Ryan Specialty from $69.00 to $66.00 and set an "equal weight" rating for the company in a research note on Thursday, April 10th. Royal Bank of Canada dropped their price objective on Ryan Specialty from $73.00 to $72.00 and set a "sector perform" rating on the stock in a research note on Friday, February 21st. UBS Group upped their price objective on shares of Ryan Specialty from $82.00 to $84.00 and gave the stock a "buy" rating in a research report on Wednesday, February 26th. TD Cowen assumed coverage on shares of Ryan Specialty in a report on Thursday, April 10th. They set a "buy" rating and a $89.00 target price on the stock. Finally, Keefe, Bruyette & Woods dropped their price target on shares of Ryan Specialty from $76.00 to $75.00 and set an "outperform" rating on the stock in a research report on Wednesday, April 9th. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating and seven have assigned a buy rating to the company's stock. According to MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $75.67.
Get Our Latest Analysis on RYAN
Ryan Specialty Stock Up 2.4 %
Shares of RYAN traded up $1.69 during trading hours on Wednesday, hitting $70.92. The company had a trading volume of 1,458,659 shares, compared to its average volume of 972,005. The company has a market capitalization of $18.58 billion, a PE ratio of 102.79, a price-to-earnings-growth ratio of 1.19 and a beta of 0.68. The company has a current ratio of 1.01, a quick ratio of 1.01 and a debt-to-equity ratio of 2.40. Ryan Specialty Holdings, Inc. has a one year low of $51.69 and a one year high of $77.16. The company's fifty day moving average price is $70.13 and its two-hundred day moving average price is $68.71.
Ryan Specialty (NYSE:RYAN - Get Free Report) last issued its quarterly earnings results on Thursday, May 1st. The company reported $0.39 EPS for the quarter, hitting the consensus estimate of $0.39. Ryan Specialty had a return on equity of 48.01% and a net margin of 9.14%. The firm had revenue of $690.17 million during the quarter, compared to analysts' expectations of $680.80 million. During the same period in the previous year, the business earned $0.35 earnings per share. The firm's revenue for the quarter was up 25.0% on a year-over-year basis. As a group, equities analysts forecast that Ryan Specialty Holdings, Inc. will post 2.29 earnings per share for the current fiscal year.
Ryan Specialty Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Tuesday, May 27th. Shareholders of record on Tuesday, May 13th will be issued a dividend of $0.12 per share. The ex-dividend date of this dividend is Tuesday, May 13th. This represents a $0.48 dividend on an annualized basis and a yield of 0.68%. Ryan Specialty's dividend payout ratio (DPR) is presently 141.18%.
Insider Buying and Selling at Ryan Specialty
In other news, EVP Brendan Martin Mulshine sold 30,000 shares of the business's stock in a transaction that occurred on Friday, March 14th. The stock was sold at an average price of $69.30, for a total value of $2,079,000.00. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Insiders own 11.10% of the company's stock.
Ryan Specialty Profile
(
Free Report)
Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.
Further Reading

Before you consider Ryan Specialty, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ryan Specialty wasn't on the list.
While Ryan Specialty currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.